 |
| Thanks to the seed funding from Hamamatsu and others, the Axithra team led by CEO Leander Van Neste will be able to carry out two years of R&D work on its chip-based Raman technology for therapeutic drug monitoring. Photo: imec/Axithra. |
| © 2024 SPIE Europe |
|
